Get the Stockscreener App
132.96
1.54%
-2.08
After Hours:
132.96
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $132.96, with a volume of 648.02K.
It is down -1.54% in the last 24 hours and up +0.55% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$135.04
Open:
$135.04
24h Volume:
648.02K
Relative Volume:
0.88
Market Cap:
$7.14B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-14.42
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-1.75%
1M Performance:
+0.55%
6M Performance:
-11.44%
1Y Performance:
-25.93%
1-Day Range:
$130.67
$135.87
1-Week Range:
$130.23
$139.32
52-Week Range:
$125.94
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
132.96 | 7.25B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Masimo sets Feb. 26 date to reveal 2025 earnings numbers - Stock Titan
Apple Again Pushes To Escape Masimo's $634M IP Verdict - Law360
Is Masimo Corporation impacted by rising ratesJuly 2025 Gainers & Real-Time Buy Signal Notifications - mfd.ru
Masimo Corporation (NASDAQ:MASI) Given Average Rating of "Hold" by Analysts - MarketBeat
Here's Why You Should Add Masimo Stock to Your Portfolio Now - Finviz
Masimo Investors' $34M Deal In Revenue Suit Gets Initial OK - Law360
Masimo’s $33.8 Million Investor Settlement Gets First Court Nod - Bloomberg Law News
Great Lakes Advisors LLC Sells 80,971 Shares of Masimo Corporation $MASI - MarketBeat
Masimo EVP Anand sells $2.56 million in shares By Investing.com - Investing.com South Africa
Masimo EVP Anand sells $2.56 million in shares - Investing.com
Owlet vs. Masimo: Which Medical Monitoring Stock Is the Better Buy? - TradingView
Why Masimo (MASI) is Poised to Beat Earnings Estimates Again - Finviz
Wall Street Analysts Think Masimo (MASI) Could Surge 31.06%: Read This Before Placing a Bet - Finviz
Strs Ohio Reduces Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo wants Apple’s bid to erase a $634 million patent-infringement verdict overturned - MacTech.com
Masimo Fights Apple Bid to Undo $634 Million Apple Watch Verdict - Bloomberg Law News
Masimo to Sell Consumer Audio Business to HARMAN for $350 Million - rAVe [PUBS]
Massachusetts Financial Services Co. MA Boosts Holdings in Masimo Corporation $MASI - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo Stock Declines Despite Solid Preliminary Q4 Revenues - TradingView
Medical Device Connectivity Market is expected to generate a revenue of USD 13.4 Billion by 2032, Globally, at 23.40% CAGR: Verified Market Research® - GlobeNewswire Inc.
Masimo Releases Preliminary Q4 Results - ocbj.com
Masimo (NASDAQ:MASI) Updates Q4 2025 Earnings Guidance - MarketBeat
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Masimo Corp. Reports Strong Q3 2025 Growth - MSN
Why Masimo Corporation (3M4) stock is a strong analyst pickPrice Action & AI Based Buy and Sell Signals - ulpravda.ru
Why Masimo Corporation stock is trending among retail tradersDay Trade & Daily Stock Trend Reports - Улправда
How rising interest rates impact Masimo Corporation stockQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - ulpravda.ru
Masimo’s Pediatric SpO2 Study With Philips Monitors: What Investors Should Watch - TipRanks
How to watch Masimo’s talk at the J.P. Morgan 2026 healthcare event - Stock Titan
Here's Why You Should Retain Masimo Stock in Your Portfolio Now - The Globe and Mail
Masimo (NASDAQ:MASI) Reaches New 12-Month LowHere's What Happened - MarketBeat
Masimo Corporation (MASI) Stock Analysis: Exploring a 44% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Weekend Round-Up: TSMC's US Export Approval, Masimo's Quality Concerns And Apple's Vision Pro Woes - Benzinga
MASI (Masimo) Net Interest Income : $-34 Mil (TTM As of Sep. 2025) - GuruFocus
Apple's Vision Pro Production Plans, Masimo's Quality Score Declines Despite Patent Win, And More: This Week In Appleverse - Benzinga
MASI (Masimo) Total Equity : $810 Mil (As of Sep. 2025) - GuruFocus
MASI Stock Price, Forecast & Analysis | MASIMO CORP (NASDAQ:MASI) - Chartmill
Apple's Rival Masimo Tumbles In Quality Despite $634 Million Patent Win Over iPhone-Maker - Benzinga
Masimo Corporation $MASI Shares Sold by Voya Investment Management LLC - MarketBeat
Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets - Finviz
Masimo Corporation stock hits 52-week low at 131.47 USD By Investing.com - Investing.com South Africa
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):